Blomqvist C - Search Results

1

Three-year oral clodronate treatment does not impair mineralization of newly formed bone--a histomorphometric study.

Saarto T, Taube T, Blomqvist C, Vehmanen L, Elomaa I. Saarto T, et al. Among authors: blomqvist c. Calcif Tissue Int. 2005 Aug;77(2):84-90. doi: 10.1007/s00223-004-0262-2. Epub 2005 Aug 11. Calcif Tissue Int. 2005. PMID: 16075363 Clinical Trial.

2

The combination of radiotherapy, adjuvant chemotherapy (cyclophosphamide-doxorubicin-ftorafur) and tamoxifen in stage II breast cancer. Long-term follow-up results of a randomised trial.

Blomqvist C, Tiusanen K, Elomaa I, Rissanen P, Hietanen T, Heinonen E, Gröhn P. Blomqvist C, et al. Br J Cancer. 1992 Dec;66(6):1171-6. doi: 10.1038/bjc.1992.430. Br J Cancer. 1992. PMID: 1457360 Free PMC article. Clinical Trial.

3

Adjuvant hormone therapy in breast cancer.

Blomqvist CP, Elomaa I, Rissanen P. Blomqvist CP, et al. Ann Med. 1992 Apr;24(2):91-6. doi: 10.3109/07853899209148333. Ann Med. 1992. PMID: 1535200 Free article.

4

Ifosfamide, vincristine, doxorubicin and dacarbazine in adult patients with advanced soft-tissue sarcoma.

Wiklund TA, Blomqvist CP, Virolainen M, Elomaa I. Wiklund TA, et al. Among authors: blomqvist cp. Cancer Chemother Pharmacol. 1992;30(2):100-4. doi: 10.1007/BF00686400. Cancer Chemother Pharmacol. 1992. PMID: 1600589 Clinical Trial.

5

FEC (5-fluorouracil-epirubicin-cyclophosphamide) monthly versus FEC weekly in metastatic breast cancer. First results of a randomized trial.

Blomqvist C, Elomaa I, Rissanen P, Hietanen P, Nevasaari K, Helle L. Blomqvist C, et al. Acta Oncol. 1992;31(2):231-6. doi: 10.3109/02841869209088908. Acta Oncol. 1992. PMID: 1622639 Review.

6

Ten years' experience in patients with osteogenic sarcoma in Finland.

Elomaa I, Siimes MA, Blomqvist C, Karaharju E, Ryöppy S, Laasonen E, Holmström T. Elomaa I, et al. Among authors: blomqvist c. Eur J Surg Oncol. 1990 Apr;16(2):147-52. Eur J Surg Oncol. 1990. PMID: 1691110

7

Type III collagen metabolism in soft tissue sarcomas.

Wiklund TA, Elomaa I, Blomqvist CP, Risteli L, Risteli J. Wiklund TA, et al. Among authors: blomqvist cp. Br J Cancer. 1992 Feb;65(2):193-6. doi: 10.1038/bjc.1992.40. Br J Cancer. 1992. PMID: 1739616 Free PMC article.

8

Postirradiation sarcoma. Analysis of a nationwide cancer registry material.

Wiklund TA, Blomqvist CP, Räty J, Elomaa I, Rissanen P, Miettinen M. Wiklund TA, et al. Among authors: blomqvist cp. Cancer. 1991 Aug 1;68(3):524-31. doi: 10.1002/1097-0142(19910801)68:3<524::aid-cncr2820680313>3.0.co;2-e. Cancer. 1991. PMID: 2065271

9

Cytogenetic investigations of patients on clodronate therapy for Paget's disease of bone.

Borgström GH, Elomaa I, Blomqvist C, Porkka L. Borgström GH, et al. Among authors: blomqvist c. Bone. 1987;8 Suppl 1:S85-6. Bone. 1987. PMID: 2825742

10

Diphosphonates for osteolytic metastases.

Elomaa I, Blomqvist C, Porkka L, Holmström T, Taube T, Lamberg-Allardt C, Borgström GH. Elomaa I, et al. Among authors: blomqvist c. Lancet. 1985 May 18;1(8438):1155-6. doi: 10.1016/s0140-6736(85)92455-9. Lancet. 1985. PMID: 2860356 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

635 results

Search Page

Filters